关注
Nick (Nicholas) Rydzewski
Nick (Nicholas) Rydzewski
National Cancer Institute
在 nih.gov 的电子邮件经过验证
标题
引用次数
引用次数
年份
A molecular mechanism to regulate lysosome motility for lysosome positioning and tubulation
X Li, N Rydzewski, A Hider, X Zhang, J Yang, W Wang, Q Gao, X Cheng, ...
Nature cell biology 18 (4), 404-417, 2016
3852016
Gross total resection and adjuvant radiotherapy most significant predictors of improved survival in patients with atypical meningioma
NR Rydzewski, MS Lesniak, JP Chandler, JA Kalapurakal, E Pollom, ...
Cancer 124 (4), 734-742, 2018
912018
The socioeconomic gradient in all-cause mortality for women with breast cancer: findings from the 1998 to 2006 National Cancer Data Base with follow-up through 2011
J Feinglass, N Rydzewski, A Yang
Annals of epidemiology 25 (8), 549-555, 2015
592015
Receipt of vaginal brachytherapy is associated with improved survival in women with stage I endometrioid adenocarcinoma of the uterus: A National Cancer Data Base study
NR Rydzewski, AE Strohl, ED Donnelly, MJ Kanis, JR Lurain, ...
Cancer 122 (23), 3724-3731, 2016
322016
Prognosis associated with luminal and basal subtypes of metastatic prostate cancer
R Aggarwal, NR Rydzewski, L Zhang, A Foye, W Kim, KT Helzer, ...
JAMA oncology 7 (11), 1644-1652, 2021
262021
Role of adjuvant external beam radiotherapy and chemotherapy in one versus two or more node-positive vulvar cancer: a National Cancer Database study
NR Rydzewski, MJ Kanis, ED Donnelly, JR Lurain, JB Strauss
Radiotherapy and Oncology 129 (3), 534-539, 2018
262018
Longitudinal molecular profiling of circulating tumor cells in metastatic renal cell carcinoma
M Bootsma, RR McKay, H Emamekhoo, RM Bade, JL Schehr, ...
Journal of Clinical Oncology 40 (31), 3633-3641, 2022
222022
Predicting cancer drug TARGETS-treatment response generalized elastic-neT signatures
NR Rydzewski, E Peterson, JM Lang, M Yu, S Laura Chang, M Sjöström, ...
NPJ genomic medicine 6 (1), 76, 2021
152021
Expression and therapeutic targeting of TROP-2 in treatment-resistant prostate cancer
JM Sperger, KT Helzer, CN Stahlfeld, D Jiang, A Singh, KR Kaufmann, ...
Clinical Cancer Research 29 (12), 2324-2335, 2023
142023
A clinical-grade liquid biomarker detects neuroendocrine differentiation in prostate cancer
SG Zhao, JM Sperger, JL Schehr, RR McKay, H Emamekhoo, A Singh, ...
The Journal of Clinical Investigation 132 (21), 2022
102022
Mortality after stereotactic radiosurgery for brain metastases and implications for optimal utilization: a national cancer database study
NR Rydzewski, AJ Khan, JB Strauss, SJ Chmura
American journal of clinical oncology 41 (11), 1142-1147, 2018
92018
Intrinsic molecular subtypes of metastatic castration-resistant prostate cancer
E Feng, NR Rydzewski, M Zhang, A Lundberg, M Bootsma, KT Helzer, ...
Clinical Cancer Research 28 (24), 5396-5404, 2022
82022
National evaluation of the new commission on cancer quality measure for postmastectomy radiation treatment for breast cancer
CA Minami, KY Bilimoria, NM Hansen, JB Strauss, JP Hayes, ...
Annals of surgical oncology 23, 2446-2455, 2016
72016
Comparative evaluation of LLMs in clinical oncology
NR Rydzewski, D Dinakaran, SG Zhao, E Ruppin, B Turkbey, DE Citrin, ...
Nejm Ai 1 (5), AIoa2300151, 2024
62024
Fragmentomic analysis of circulating tumor DNA-targeted cancer panels
KT Helzer, MN Sharifi, JM Sperger, Y Shi, M Annala, ML Bootsma, ...
Annals of Oncology 34 (9), 813-825, 2023
52023
A phase 1 trial of focal salvage stereotactic body radiation therapy for radiorecurrent prostate cancer
KR Patel, NR Rydzewski, E Schott, T Cooley-Zgela, H Ning, J Cheng, ...
Practical Radiation Oncology 13 (6), 540-550, 2023
42023
Identification of phenocopies improves prediction of targeted therapy response over DNA mutations alone
H Bakhtiar, KT Helzer, Y Park, Y Chen, NR Rydzewski, ML Bootsma, ...
NPJ Genomic Medicine 7 (1), 58, 2022
42022
Clinical implications of scleroderma in the decision for radiotherapy-based larynx preservation
NR Rydzewski, PM Harari, GK Hartig, D Francis, ME Witek
JAMA Otolaryngology–Head & Neck Surgery 146 (3), 308-309, 2020
32020
Radiosensitization of glioblastoma using targeted inhibition of N-myristoylation
D Dinakaran, E Wilson, NR Rydzewski, KA Camphausen
International Journal of Radiation Oncology, Biology, Physics 117 (2), e226, 2023
12023
Radiomic modeling of bone density and rib fracture risk after stereotactic body radiation therapy for early-stage non-small cell lung cancer
NR Rydzewski, P Yadav, HB Musunuru, KM Condit, D Francis, SG Zhao, ...
Advances in Radiation Oncology 7 (3), 100884, 2022
12022
系统目前无法执行此操作,请稍后再试。
文章 1–20